Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.

GrinyĆ³ JM, Del Carmen Rial M, Alberu J, Steinberg SM, Manfro RC, Nainan G, Vincenti F, Jones-Burton C, Kamar N.

Am J Kidney Dis. 2017 May;69(5):587-594. doi: 10.1053/j.ajkd.2016.09.021. Epub 2016 Nov 23.

2.

A single arm, prospective, open label, multicentre study for evaluation of efficacy and safety of IV CERA for treatment of chronic renal anaemia in dialysis patients not currently treated with ESA.

Nainan GK, Pathak VR, Dalal SS, Saxena S, Mittal D, Raju TR, Gokulnath, Isaac R, Rajapurkar MM, Rana DS, Shah BV, Ray DS, Thiagarajan CM, Jha RM, Kukreja AA, Pophale RR.

J Assoc Physicians India. 2014 Mar;62(3):232-6.

PMID:
25327065
3.

Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study.

Farag YM, Mittal BV, Keithi-Reddy SR, Acharya VN, Almeida AF, C A, Ballal HS, Gaccione P, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rajapurkar MM, Rana DS, Sreedhara R, Sinha DK, Shah BV, Sunder S, Sharma RK, Seetharam S, Raju TR, Singh AK.

BMC Nephrol. 2014 Mar 6;15:42. doi: 10.1186/1471-2369-15-42.

4.

Chromoblastomycosis in a renal allograft recipient.

Sooraj YS, Nainan GK, Eapen M, Immanuel AJ, Pillai RR.

Indian J Nephrol. 2013 May;23(3):235-6. doi: 10.4103/0971-4065.111868. No abstract available.

5.

Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study.

Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, Almeida AF, Channakeshavamurthy A, Ballal HS, P G, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rana DS, Sreedhara R, Sinha DK, V SB, Sunder S, Sharma RK, Seetharam S, Raju TR, Rajapurkar MM.

BMC Nephrol. 2013 May 28;14:114. doi: 10.1186/1471-2369-14-114.

6.

Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study.

Grinyo J, Alberu J, Contieri FL, Manfro RC, Mondragon G, Nainan G, Rial Mdel C, Steinberg S, Vincenti F, Dong Y, Thomas D, Kamar N.

Transpl Int. 2012 Oct;25(10):1059-64. doi: 10.1111/j.1432-2277.2012.01535.x. Epub 2012 Jul 21.

7.

Emphysematous polycystic renal infection.

Sooraj YS, Nainan GK, Joseph F, Thara P.

Indian J Nephrol. 2010 Oct;20(4):205-6. doi: 10.4103/0971-4065.73457.

8.

Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.

Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G, Thomas D, GrinyĆ³ J.

Clin J Am Soc Nephrol. 2011 Feb;6(2):430-9. doi: 10.2215/CJN.05840710. Epub 2010 Nov 4.

9.

First evidence of fatal hantavirus nephropathy in India, mimicking leptospirosis.

Clement J, Maes P, Muthusethupathi M, Nainan G, van Ranst M.

Nephrol Dial Transplant. 2006 Mar;21(3):826-7. Epub 2005 Dec 16. No abstract available.

PMID:
16361279

Supplemental Content

Loading ...
Support Center